Wilkinson CL - Search Results

1

Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product Approval.

Chambers JD, Thorat T, Wilkinson CL, Salem M, Subedi P, Kamal-Bahl SJ, Neumann PJ. Chambers JD, et al. Among authors: wilkinson cl. Appl Health Econ Health Policy. 2017 Apr;15(2):227-235. doi: 10.1007/s40258-016-0291-9. Appl Health Econ Health Policy. 2017. PMID: 27832480

2

Drugs Cleared Through The FDA's Expedited Review Offer Greater Gains Than Drugs Approved By Conventional Process.

Chambers JD, Thorat T, Wilkinson CL, Neumann PJ. Chambers JD, et al. Among authors: wilkinson cl. Health Aff (Millwood). 2017 Aug 1;36(8):1408-1415. doi: 10.1377/hlthaff.2016.1541. Health Aff (Millwood). 2017. PMID: 28784733

3

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted.

Neumann PJ, Thorat T, Zhong Y, Anderson J, Farquhar M, Salem M, Sandberg E, Saret CJ, Wilkinson C, Cohen JT. Neumann PJ, et al. PLoS One. 2016 Dec 22;11(12):e0168512. doi: 10.1371/journal.pone.0168512. eCollection 2016. PLoS One. 2016. PMID: 28005986 Free PMC article. Review.

4

Specialty Drug Coverage Varies Across Commercial Health Plans In The US.

Chambers JD, Kim DD, Pope EF, Graff JS, Wilkinson CL, Neumann PJ. Chambers JD, et al. Among authors: wilkinson cl. Health Aff (Millwood). 2018 Jul;37(7):1041-1047. doi: 10.1377/hlthaff.2017.1553. Health Aff (Millwood). 2018. PMID: 29985695

5

Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies.

Chambers JD, Pope EF, Wilkinson CL, Neumann PJ. Chambers JD, et al. Among authors: wilkinson cl. J Manag Care Spec Pharm. 2018 Dec;24(12):1240-1246. doi: 10.18553/jmcp.2018.24.12.1240. J Manag Care Spec Pharm. 2018. PMID: 30479201 Free PMC article.

6

Variation in Private Payer Coverage of Rheumatoid Arthritis Drugs.

Chambers JD, Wilkinson CL, Anderson JE, Chenoweth MD. Chambers JD, et al. Among authors: wilkinson cl. J Manag Care Spec Pharm. 2016 Oct;22(10):1176-81. doi: 10.18553/jmcp.2016.22.10.1176. J Manag Care Spec Pharm. 2016. PMID: 27668566 Free PMC article.

7

The influence of time horizon on results of cost-effectiveness analyses.

Kim DD, Wilkinson CL, Pope EF, Chambers JD, Cohen JT, Neumann PJ. Kim DD, et al. Among authors: wilkinson cl. Expert Rev Pharmacoecon Outcomes Res. 2017 Dec;17(6):615-623. doi: 10.1080/14737167.2017.1331432. Epub 2017 May 23. Expert Rev Pharmacoecon Outcomes Res. 2017. PMID: 28504026

8

Lack of Cost-Effectiveness Analyses to Address Healthy People 2020 Priority Areas.

Neumann PJ, Farquhar M, Wilkinson CL, Lowry M, Gold M. Neumann PJ, et al. Among authors: wilkinson cl. Am J Public Health. 2016 Dec;106(12):2205-2207. doi: 10.2105/AJPH.2016.303361. Epub 2016 Sep 15. Am J Public Health. 2016. PMID: 27631752 Free PMC article.

9

Examining Concurrent Associations Between Gesture Use, Developmental Domains, and Autistic Traits in Toddlers With Down Syndrome.

La Valle C, Mejia GD, Wilkinson CL, Baumer N. La Valle C, et al. Among authors: wilkinson cl. J Speech Lang Hear Res. 2025 Jan 22:1-11. doi: 10.1044/2024_JSLHR-24-00111. Online ahead of print. J Speech Lang Hear Res. 2025. PMID: 39841862

10

Resting state EEG in young children with Tuberous Sclerosis Complex: associations with medications and seizures.

Clements CC, Engelstad AM, Wilkinson CL, Hyde C, Hartney M, Simmons A, Tager-Flusberg H, Jeste S, Nelson CA. Clements CC, et al. Among authors: wilkinson cl. J Neurodev Disord. 2025 Jan 18;17(1):2. doi: 10.1186/s11689-025-09590-z. J Neurodev Disord. 2025. PMID: 39827117 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters